Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C

BACKGROUND: This study aimed to examine the therapeutic effect and prognostic indicators of pegylated interferon (PEG-IFN) and ribavirin (RBV) combination therapy in thrombocytopenic patients with chronic hepatitis C, hepatitis C virus (HCV)-related cirrhosis, and those who underwent splenectomy or...

Descripción completa

Detalles Bibliográficos
Autores principales: Aizawa, Nobuhiro, Enomoto, Hirayuki, Takashima, Tomoyuki, Sakai, Yoshiyuki, Iwata, Kazunari, Ikeda, Naoto, Tanaka, Hironori, Iwata, Yoshinori, Saito, Masaki, Imanishi, Hiroyasu, Iijima, Hiroko, Nishiguchi, Shuhei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2013
Materias:
Original Article—Liver, Pancreas, and Biliary Tract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124258/
https://www.ncbi.nlm.nih.gov/pubmed/24065124
http://dx.doi.org/10.1007/s00535-013-0884-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124258/
https://www.ncbi.nlm.nih.gov/pubmed/24065124
http://dx.doi.org/10.1007/s00535-013-0884-0

Ejemplares similares